Cellarity

A unique approach to drug discovery

Somerville, United States · Founded 2017 · $294.0M raised

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$294.0M
Last Round
$121.0M Series COct 2022
Rounds
3

About

Cellarity is a Flagship Pioneering-founded therapeutics company that designs medicines by studying entire cell states rather than single molecular targets. Using integrated multi-omics data and AI, its platform maps networks of cell and gene interactions to design oral Cell State-Correcting therapeutics that restore proper cell function in diseases like sickle cell disease.

Summary

Cellarity is an Artificial Intelligence company based in Somerville, United States, founded in 2017. It has raised $294.0M in total across 3 rounds, most recently a $121.0M Series C round in Oct 2022. Investors include Flagship Pioneering, Kyowa Kirin and Hanwha.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries COct 2022
$121.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies